Dyne Therapeutics, Inc. (DYN)

20.52 +0.67 (+3.38%) USD  |  NASDAQ  |  Dec 22, 13:06
More

Dyne Therapeutics EPS Diluted from Continuing Operations (Quarterly)

EPS Diluted from Continuing Operations (Quarterly) Chart

View EPS Diluted from Continuing Operations (Quarterly) for DYN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Continuing Operations (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Continuing Operations (Quarterly) Range, Past 5 Years

View EPS Diluted from Continuing Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Continuing Operations (Quarterly) Benchmarks

View EPS Diluted from Continuing Operations (Quarterly) Benchmarks
Start Trial
Avidity Biosciences, Inc. Upgrade
MannKind Corp. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Denali Therapeutics, Inc. Upgrade
Kymera Therapeutics, Inc. Upgrade